Citigroup’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08K | Buy |
3,539
+3,536
| +117,867% | +$7.07K | ﹤0.01% | 4497 |
|
|
2025
Q1 | $8 | Hold |
3
| – | – | ﹤0.01% | 4706 |
|
|
2024
Q4 | $9 | Sell |
3
-1,226
| -100% | -$3.68K | ﹤0.01% | 4903 |
|
|
2024
Q3 | $3.7K | Buy |
1,229
+1,226
| +40,867% | +$3.69K | ﹤0.01% | 4559 |
|
|
2024
Q2 | $10 | Sell |
3
-34,903
| -100% | -$116K | ﹤0.01% | 4736 |
|
|
2024
Q1 | $184K | Sell |
34,906
-23,471
| -40% | -$124K | ﹤0.01% | 3323 |
|
|
2023
Q4 | $300K | Buy |
58,377
+58,336
| +142,283% | +$300K | ﹤0.01% | 2994 |
|
|
2023
Q3 | $214 | Hold |
41
| – | – | ﹤0.01% | 4547 |
|
|
2023
Q2 | $76 | Buy |
41
+36
| +720% | +$67 | ﹤0.01% | 4705 |
|
|
2023
Q1 | $19 | Sell |
5
-47
| -90% | -$179 | ﹤0.01% | 4641 |
|
|
2022
Q4 | $161 | Sell |
52
-47
| -47% | -$146 | ﹤0.01% | 4806 |
|
|
2022
Q3 | $0 | Sell |
99
-338
| -77% | – | ﹤0.01% | 5431 |
|
|
2022
Q2 | $12K | Buy |
437
+197
| +82% | +$5.41K | ﹤0.01% | 4569 |
|
|
2022
Q1 | $9K | Sell |
240
-13,511
| -98% | -$507K | ﹤0.01% | 4812 |
|
|
2021
Q4 | $804K | Buy |
13,751
+7,916
| +136% | +$463K | ﹤0.01% | 2743 |
|
|
2021
Q3 | $480K | Buy |
5,835
+5,531
| +1,819% | +$455K | ﹤0.01% | 2921 |
|
|
2021
Q2 | $29K | Sell |
304
-1,438
| -83% | -$137K | ﹤0.01% | 4433 |
|
|
2021
Q1 | $111K | Buy |
+1,742
| New | +$111K | ﹤0.01% | 3662 |
|